BVT Call 190 PGR 20.09.2024/ DE000VM728C2 /
2024-05-17 8:48:04 AM | Chg.-0.21 | Bid10:00:05 PM | Ask10:00:05 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.43EUR | -7.95% | - Bid Size: - |
- Ask Size: - |
Progressive Corporat... | 190.00 USD | 2024-09-20 | Call |
GlobeNewswire
2:00 PM
Intercept Presents New Data Demonstrating the Impact of OCA-Bezafibrate Combination Therapy on ALP a...
GlobeNewswire
05-16
BMW unveils The BMW XM Mystique Allure, a one-of-a-kind luxury vehicle inspired by the iconic superm...
GlobeNewswire
05-15
Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III P...
GlobeNewswire
05-14
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment...
GlobeNewswire
05-13
Avalyn Announces Multiple Presentations on its Lead Program, AP01, for Pulmonary Fibrosis and its Ap...
GlobeNewswire
05-13
BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transt...
GlobeNewswire
05-13
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...
GlobeNewswire
05-09
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st ...
GlobeNewswire
05-09
Freeline Presents Positive New Data from Phase 1/2 Trial of FLT201, Its Novel Gene Therapy Candidate...
GlobeNewswire
05-08
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Plan...
GlobeNewswire
05-07
MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-1...
GlobeNewswire
05-06
Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...
GlobeNewswire
05-04
The National Fire Sprinkler Association's Class of 2024: Honoring Fire Sprinkler Industry Greats
GlobeNewswire
05-02
PyroGenesis Announces 28-Day Lab Strength Tests Achieve Up to 99.56% Above Compressive Strength Targ...
GlobeNewswire
05-01
Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...
GlobeNewswire
05-01
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 ...
GlobeNewswire
05-01
Atsena Therapeutics Announces Positive Clinical Data from the First Cohort of Phase I/II Trial Evalu...
GlobeNewswire
05-01
TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results